PRO DEX INC
For the period ended Dec 31, 2024. Filed Jan 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2024 · Filed Jan 30, 2025
PDEX$69.86-0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Six Months Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net income (loss) | $4,506 | $(115) |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 615 | 568 |
| Share-based compensation | 243 | 386 |
| Unrealized (gain) loss on marketable equity investments | (510) | 2,593 |
| Non-cash lease recovery | (14) | (7) |
| Amortization of loan fees, net | 13 | — |
| Credit loss expense | 27 | — |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (4,606) | (3,217) |
| Deferred costs | 109 | 82 |
| Inventory | (4,342) | 1,141 |
| Prepaid expenses and other assets | (991) | (605) |
| Accounts payable and accrued expenses | 3,030 | 340 |
| Deferred revenue | (14) | — |
| Income taxes payable | (329) | (64) |
| Net cash provided by (used in) operating activities | (2,263) | 1,102 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchases of investments | — | (1,250) |
| Purchases of equipment and improvements | (973) | (759) |
| Net cash used in investing activities | (973) | (2,009) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Repurchases of common stock | (3,504) | (107) |
| Proceeds from ESPP contributions | 15 | 32 |
| Payment of employee payroll taxes on net issuance of common stock | (305) | — |
| Proceeds from Minnesota Bank & Trust revolving loan | 8,490 | 2,000 |
| Principal payments on notes payable and revolving loan | (4,025) | (2,665) |
| Net cash provided by (used in) financing activities | 671 | (740) |
| Net decrease in cash and cash equivalents | (2,565) | (1,647) |
| Cash and cash equivalents, beginning of period | 2,631 | 2,936 |
| Cash and cash equivalents, end of period | $66 | $1,289 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.